Risk factors for oral soft tissue lesions in an adult Spanish population

Vallejo, María José García-Pola; Díaz-Canel, Ana Isabel Martínez; Martin, Jeanette; García, Gema Alejandra Botana

doi:10.1034/j.1600-0528.2002.00048.x

Cited by 95 publications

(69 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Epithelial diseases accounted for 8.8% of our sample, similarly to Garcia-Polla Vallejo et al 1 (9.1%), but higher than Pentenero et al 5 (3.5%), Kovac-Kovacic and Skaleric 9 (5.3%) and Dundar and Ilhan Kal 14 (6.5%). Potentially malignant disorders of the oral cavity and oral cancer are included within this group and represented together about 41% of all lesions diagnosed in our patients.…”

Section: Discussionsupporting

confidence: 62%

“…Several studies have been conducted with population-based samples [1][2][3][4][5]8 and these will probably show different results when compared to studies conducted at universities and centers of specialized health care, with individuals searching for assistance (convenience samples) 6,[9][10][11][12][13] . Studies conducted in dental schools, both with patients in routine dental treatment or referred for stomatological evaluation, in spite of probably showing a different picture from the general population, may better represent a model of what occurs in daily practice of the profession 6,[11][12][13][14] .…”

Section: Discussionmentioning

confidence: 99%

“…Studies reporting on the prevalence of oral diseases in different countries from all continents have been reported in the literature in a regular basis in the last years [1][2][3][4][5][6] . They are essential in highlighting epidemiologic, geographic and racial biases and similarities among different populations, offering the possibility of comparing health service needs in different countries and regions.…”

Section: Introductionmentioning

confidence: 99%

“…Most reports have focused on the prevalence of oral and maxillofacial diseases in specific groups, including only soft--tissue lesions, lesions from a specific anatomic location, lesions from a specific age group, lesions diagnosed in oral and maxillofacial surgical pathology laboratories, lesions diagnosed in convenience samples and lesions diagnosed in population-based studies [1][2][3][4][5][6] . Although all studies have their specific and individual importance when studying the epidemiology of oral diseases, they do not reflect the real incidence of oral lesions in a regular Stomatology service.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Prevalence of oral and maxillofacial diseases diagnosed in an Oral Medicine service during a 7-year period

Amaral¹,

Miranda²,

Netto³

et al. 2016

JORDI - Journal of Oral Diagnosis

View full text Add to dashboard Cite

AbstrAct:Prevalence of oral and maxillofacial diseases is highly variable depending on the region, country and source of the data. The aim of this study was to determine the prevalence of oral and maxillofacial diseases diagnosed in an Oral Medicine service during a 7-year period. All clinical charts from patients attending the service in the period were reviewed to retrieve demographic and clinical data; diagnosis were classified in groups, distributed in absolute and relative values and analyzed with respect to their frequency. A total of 1075 clinical charts were reviewed and females represented 60% of the sample. Mean age of the patients was 41 years (ranging from 1 month to 94 years old) and most patients were in their fourties to fifties. A total of 1444 oral diseases were diagnosed and the most prevalent groups were soft-tissue tumors (184 cases, 12.7%), developmental defects (161, 11.2%) and epithelial diseases (127, 8.8%). Individually, the most frequent diseases included fibrous hyperplasias (120 cases, 8.3%), candidosis (77, 5.3%), periradicular inflammatory lesions (72, 5.0%) and potentially malignant disorders (52, 3.6%). Oral carcinomas represented 2.5% of the sample (36 cases). The present results reflect the frequency of oral diseases diagnosed in a specialized service in southeastern Brazil and will allow the establishment of preventive strategies and the adequacy of the clinical services offered to the target population.

show abstract

Section: Discussionsupporting

confidence: 62%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Prevalence of oral and maxillofacial diseases diagnosed in an Oral Medicine service during a 7-year period

Amaral¹,

Miranda²,

Netto³

et al. 2016

JORDI - Journal of Oral Diagnosis

View full text Add to dashboard Cite

show abstract

“…The reported prevalence rates of OLP vary from 0.05 to 3.2% of the general population, with the highest frequency among women [1]. Despite extensive research, the etiology of OLP and the development mechanism are still unknown.…”

Section: Introductionmentioning

confidence: 99%

Thyroid Disease and Oral Lichen Planus as Comorbidity: A Prospective Case-Control Study

García-Pola¹,

Llorente-Pendás²,

Romero³

et al. 2016

Dermatology

View full text Add to dashboard Cite

Background: Thyroid disease has been mentioned to have a possible relation to the development of oral lichen planus (OLP). Objective: Because goiter is considered endemic in many countries, we proposed to determine whether thyroid disease constitutes a comorbidity of OLP. Methods: Two hundred and fifteen patients diagnosed as having OLP were evaluated concerning their serum thyroid-stimulating hormone and thyroxine (T₄) levels. The results were contrasted with those obtained in control series of the same number of subjects matched for age and sex. Results: Diagnosis of thyroid disease was present in 15.3% of OLP patients (33/215) and in 5.2% (12/215) of the control group. In relation to OLP patients, the odds ratio of presence of thyroid disorders was 3.06 and that of using levothyroxine medication 3.21. Conclusions: In the present study, OLP patients were associated with thyroid disease, specifically with hypothyroidism. Because most thyroid patients need T₄ treatment, our findings confirmed that OLP and thyroid disease could be comorbidities.

show abstract

Global Prevalence and Incidence Estimates of Oral Lichen Planus

et al. 2020

View full text Add to dashboard Cite

IMPORTANCE Integrated information on the global prevalence and incidence of oral lichen planus (OLP) is lacking.OBJECTIVE To examine the global prevalence and incidence of OLP in a systematic review and meta-analysis.DATA SOURCES A systematic review of population-based studies and clinic-based studies reporting the prevalence and incidence of OLP was performed using 3 electronic medical databases (Cochrane Database of Systematic Reviews, Embase, and MEDLINE) from their inception to March 2019. The search terms included "(lichen planus or LP) and (prevalence or incidence or epidemiology)." No language restriction was applied.STUDY SELECTION Observational descriptive studies investigating the prevalence and incidence of OLP were included.DATA EXTRACTION AND SYNTHESIS Data were extracted by continent, sex, and other characteristics. The risk of bias was assessed by the Joanna Briggs Institute Critical Appraisal Instrument for Studies Reporting Prevalence Data using random-effects models to synthesize available evidence. MAIN OUTCOMES AND MEASURESThe primary outcome was the prevalence (with 95% CIs) of OLP among the overall population and among subgroups. Between-study heterogeneity was assessed using the I 2 statistic. RESULTS Among 46 studies, the overall pooled estimated prevalence of OLP was 0.89% (95% CI, 0.38%-2.05%) among the general population (n = 462 993) and 0.98% (95% CI, 0.67%-1.43%) among clinical patients (n = 191 963). Among the 15 population-based studies, the prevalence of OLP was 0.57% (95% CI, 0.15%-2.18%) in Asia, 1.68% (95% CI, 1.09%-2.58%) in Europe, and 1.39% (95% CI, 0.58%-3.28%) in South America. Among the 31 clinic-based studies, the prevalence was 1.43% (95% CI, 1.12%-1.83%) in Africa, 0.87% (95% CI, 0.61%-1.25%) in Asia, 1.03% (95% CI, 0.51%-2.09%) in Europe, 0.11% (95% CI, 0.07%-0.16%) in North America, and 3.18% (95% CI, 0.97%-9.95%) in South America. The pooled prevalence of OLP by sex was 1.55% (95% CI, 0.83%-2.89%) for women and 1.11% (95% CI, 0.57%-2.14%) for men in the population-based studies and 1.69% (95% CI, 1.05%-2.70%) for women and 1.09% (95% CI, 0.67%-1.77%) for men in the clinic-based studies. In 5 clinic-based studies providing the age distribution of patients with OLP, the prevalence by age was 0.62% (95% CI, 0.33%-1.13%) among patients younger than 40 years and 1.90% (95% CI, 1.16%-3.10%) among patients 40 years and older.CONCLUSIONS AND RELEVANCE This study identified the global prevalence and incidence of OLP in terms of its spatial, temporal, and population distribution. The overall estimated pooled prevalence of OLP was 0.89% among the general population and 0.98% among clinical patients. A higher prevalence of OLP was found in non-Asian countries, among women, and among people 40 years and older. The findings should be considered with caution because of the high heterogeneity of the included studies.

show abstract

Risk factors for oral soft tissue lesions in an adult Spanish population

Cited by 95 publications

References 45 publications

Prevalence of oral and maxillofacial diseases diagnosed in an Oral Medicine service during a 7-year period

Prevalence of oral and maxillofacial diseases diagnosed in an Oral Medicine service during a 7-year period

Thyroid Disease and Oral Lichen Planus as Comorbidity: A Prospective Case-Control Study

Global Prevalence and Incidence Estimates of Oral Lichen Planus

Contact Info

Product

Resources

About